Clinical Trials · NCT04680767
A Study of LY3502970 in Healthy Male Participants
- Phase
- Phase 1
- Recruitment status
- Completed
- Sponsor
- Eli Lilly and Company
- Enrollment
- 6
- Start date
- Mar 2021
- Locations
- 1 site, United Kingdom
- Primary endpoint
- Feces Excretion of LY3502970 Radioactivity Over Time Expressed as a Percentage of the Total Radioactive Dose Administered